Insights Articles
Articles
FDA Leaders Propose New “Plausible Mechanism Pathway” for Development and Approval of Drugs and Biologics
November 20, 2025
| Thomson Reuters Westlaw Today

Go to the article

Related Capabilities
FDA & Life Sciences
Featured Lawyers
Person Beverly Lorell
Bev H. Lorell, M.D. (Beverly)
Consultant
Government Matters & Regulation
Person Christina Markus
Christina M. Markus (Chris)
Partner
Government Matters & Regulation
Person Dennis Sampson
D. Kyle Sampson
Partner
Government Matters & Regulation
Person Lauren Roth
Lauren K. Roth
Partner
Government Matters & Regulation
Explore King & Spalding
a blue and green background
Capabilities
FDA & Life Sciences
Learn More

The Best and Latest Insights
All in One Place.

Subscribe